In a one-on-one interview with MD+DI, Dexcom CEO Kevin Sayer shares the company's biggest lesson from 2021, expectations for G7, his concerns about the supply chain, and more.

The device is designed to improve decongestion in acutely decompensated heart failure (ADHF) patients.

The Dublin-based company said the device was the world’s smallest pacemaker and it can now treat patients with AV block.

The partnership will leverage Glytec's insulin dosing support software to address challenges with hospital inpatient blood sugar management.

After a successful early feasibility study in the United States, the TRIA biopolymer valve will be studied globally, beginning in India.

The proceeds from the $75 million funding will be used for the European launch of the company’s updated Kaleido insulin patch pump system.

Vibration-controlled transient elastography (VCTE) technology could be used to detect liver disease early and to monitor interventions.   

Abbott is sitting on a ton of cash. So how will the company prioritize spending in 2022?

Updated rates posted by Medicare Administrative Contractor Novitas may be a positive sign for the company.

The acquisition expands Medtronic's portfolio of advanced cardiac ablation products and accessories, including first-time entry into cardiac mapping and navigation systems.